Impact of high-throughput screening in biomedical research.

Macarron, Ricardo; Banks, Martyn N; Bojanic, Dejan; Burns, David J; Cirovic, Dragan A; Garyantes, Tina; Green, Darren V S; Hertzberg, Robert P; Janzen, William P; Paslay, Jeff W; Schopfer, Ulrich; Sittampalam, G Sitta

Macarron, Ricardo; Banks, Martyn N; Bojanic, Dejan; Burns, David J; Cirovic, Dragan A; Garyantes, Tina; Green, Darren V S; Hertzberg, Robert P; Janzen, William P; Paslay, Jeff W; Schopfer, Ulrich; Sittampalam, G Sitta.

Affiliation

Macarron R; Department of Sample Management Technologies, GlaxoSmithKline, Mail Stop UP 12-200, 1250S Collegeville Rd, Collegeville, Pennsylvania 19426, USA. ricardo.macarron@gsk.com

Nat Rev Drug Discov ; 10(3): 188-95, 2011 03.

Article in En | MEDLINE | ID: mdl-21358738

Subject(s)

Biomedical Research; Drug Evaluation, Preclinical; Animals; Drug Design; Drug Evaluation, Preclinical/standards; Drug Evaluation, Preclinical/statistics & numerical data; Humans; Small Molecule Libraries

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biomedical Research / Drug Evaluation, Preclinical Type of study: Diagnostic_studies / Prognostic_studies / Screening_studies Limits: Animals / Humans Language: En Journal: Nat Rev Drug Discov Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2011 Document type: Article Affiliation country: United States Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google